With more than a third of the participants reporting potential harms to patients with cancer from the disruption of usual care, some centers reported that up to 80% of their patients had exposure to potential harms. Although these numbers varied among centers, patient harm was certainly encountered by many oncologists because of the pandemic. The exact magnitude should be determined with time and future systematic studies because there are different risks of harm, including issues related to cancer management and noncancer-related management of other medical conditions that affect patients with cancer. The spectrum of cancer-related harm is wide and includes halting screen-ing and prevention efforts, delaying timely diagnosis and staging of new patients, delaying initiation of therapy, interrupting ongoing treatment, delivering suboptimal palliative care, and disrupting clinical research.32,33